Incidence of deep vein thrombosis from screening by venous ultrasonography in Japanese patients

  • Yu MorishitaEmail author
  • Masahiko Fujihara
Original Article


The aim of the present study was to investigate the incidence of deep vein thrombosis (DVT) patients in a Japanese population by screening them with venous ultrasonography. This retrospective, single-center analysis examined 963 patients who underwent venous ultrasonography in 2015. The primary outcome was the incidence of DVT, and secondary outcomes were predictive factors of DVT in patient characteristics, treatment strategy for DVT patients, and proportion of post thrombotic syndrome (PTS). The overall incidence rate of DVT was 10.3% (100/963). The location of thrombus was the iliac vein in 3.6% (n = 35), the femoral vein in 4.4% (n = 43), and the calf vein in 8.2% (n = 79) of the patients. The main complaint or purpose of examination was perioperative screening in 37% of the patients, leg edema and/or limb swelling in 27% of the patients, and skin disease in 8% of the patients. In a multivariate analysis, the incidence of DVT was significantly higher in the hospitalization group and the "having symptoms" group. Fifty percent of DVTs received treatment, and almost all therapies were medical treatment with oral anticoagulants (OAC). Within a three-year follow-up period, the proportion of PTS was 27% with no significant difference between anticoagulation or non-anticoagulation patients; the risk of PTS was in concomitant varicose veins. In conclusion, of the patients, 10.3% were diagnosed with DVT, and only half received treatment with only anticoagulation.


Deep vein thrombosis Post-thrombotic syndrome Ultrasonography Oral anticoagulant therapy 



The authors would like to thank the cardio vascular ultrasound laboratory staff and clinical research coordinators.


The authors have received no financial support for the research, authorship, and publication of this article.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Pollack CV Jr (2011) Advanced management of acute iliofemoral deep vein thrombosis: emergence department and beyond. Ann Emerg Med 57:590–599CrossRefPubMedGoogle Scholar
  2. 2.
    White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethic groups in California. Ann Intern Med 128:737–740CrossRefPubMedGoogle Scholar
  3. 3.
    Liew NC, Alemany GV, Angchaisuksiri P, Bang SM, Choi G, De Silva DS, Hong JM, Lee L, Li YJ, Rajamoney GN, Suviraj J (2017) Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Int Angiol 36:1–20PubMedGoogle Scholar
  4. 4.
    Kahn SR, Hirsch A, Shrier I (2002) Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 162:1144–1148CrossRefPubMedGoogle Scholar
  5. 5.
    Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA (2014) Secular trends in occurrence of acute venous thromboembolism: the Worcester venous thromboembolism study (1985 to 2009). Am J Med 127:829–839CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nakamura M, Miyata T, Ozeki Y, Takayama M, Komori K, Yamada N, Origasa H, Satokawa H, Maeda H, Tanabe N, Unno N, Shibuya T, Tanemoto K, Kondo K, Kojima T (2014) Current venous thromboembolism management and outcome in Japan. Circ J 78:708–717CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka S, Nishigami K, Taniguchi N, Matsuo H, Hirai T, Kaneda S, Ogasawara M, Satoh H, Tobe H (2008) Criteria for ultrasound diagnosis of deep venous thrombosis of lower extremities. J Med Ultrason (2001) 35:33–36CrossRefGoogle Scholar
  8. 8.
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593CrossRefGoogle Scholar
  9. 9.
    Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS (2008) Determinants and time course of the post thrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 149:698–707CrossRefPubMedGoogle Scholar
  10. 10.
    Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific, and Standardization Committee of the International Society on Thrombosis, and Haemostasis (2009) Definition of the post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost 7:879–883CrossRefPubMedGoogle Scholar
  11. 11.
    Ouriel K, Green RM, Greenberg RK, Clair DG (2000) The anatomy of deep venous thrombosis of the lower extremity. J Vasc Surg 31(5):895–900CrossRefPubMedGoogle Scholar
  12. 12.
    Fard MN, Mostaan M, Anaraki MR (2001) Utility of lower-extremity duplex sonography in patients with venous thromboembolism. J Clin Ultrasound 29(2):92–98CrossRefPubMedGoogle Scholar
  13. 13.
    Virchow R (1851) Uber die Erweiterung Kleiner Gefasse. Arch Path Anat 3:427CrossRefGoogle Scholar
  14. 14.
    EndenT, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group (2012) Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis(the CaVenT study): a randomized controlled trial. Lancet 379:31–38CrossRefGoogle Scholar
  15. 15.
    Sharifi M, Bay C, Mehdipour M, Sharifi J, Investigators TORPEDO (2012) Thrombus obliteration by rapid percutaneous endovenous intervention in deep venous occlusion (TORPEDO) trial: midterm results. J Endovasc Ther 19:273–280CrossRefPubMedGoogle Scholar
  16. 16.
    Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP (2017) Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 377:2240–2252CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE (2018) Rivaroxaban for thromboprophylaxis after hospitalization for medical illness. N Engl J Med 379:1118–1127CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of CardiologyKishiwada Tokushukai HospitalKishiwadaJapan
  2. 2.Department of Medicine and Biosystemic ScienceKyushu University Graduate School of Medical SciencesFukuokaJapan

Personalised recommendations